Annotated Medicine and Device Lists


Oseltamivir

This medicine is present in:

List Section Observation
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
BLISTER X 10 CÁPSULAS
Belize. National Drug Formulary 06.04.01 Antiherpes medicines No observations

This medicine is present in:

List Section Observation
Bahamas. Drug Formulary 03. RESPIRATORY DRUGS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.4.3. Other antivirals Others observations:
Oseltamivir should be used only in compliance with the WHO treatment guidelines, i.e. (1) for treatment of patients with severe or progressive clinical illness with confirmed or suspected influenza pandemic (H1N1) 2009, (2) for the treatment of patients with confirmed or suspected but uncomplicated illness due to pandemic influenza virus infection who were in higher risk groups, most notably for pregnant women and children under 2 years of age.
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.07 ANTIVIRALS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.4.3. Other antivirals Others observations:
Oseltamivir should be used only in compliance with the WHO treatment guidelines, i.e. (1) for treatment of patients with severe or progressive clinical illness with confirmed or suspected influenza pandemic (H1N1) 2009, (2) for the treatment of patients with confirmed or suspected but uncomplicated illness due to pandemic influenza virus infection who were in higher risk groups, most notably for pregnant women and children under 2 years of age.
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.07 ANTIVIRALS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.4.3. Other antivirals Others observations:
Oseltamivir should be used only in compliance with the WHO treatment guidelines, i.e. (1) for treatment of patients with severe or progressive clinical illness with confirmed or suspected influenza pandemic (H1N1) 2009, (2) for the treatment of patients with confirmed or suspected but uncomplicated illness due to pandemic influenza virus infection who were in higher risk groups, most notably for pregnant women and children under 2 years of age.
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 05 ANTIVIRALES DE USO SISTÉMICO No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
El Salvador - 2019 ANTIVIRALES DE USO SISTÉMICO No observations

This medicine is present in:

List Section Observation
Paraguay. Lista de Medicamentos Esenciales. 2009 05. ANTIVIRALES DE USO SISTÉMICO No observations
Belize. National Drug Formulary 06.04.01 Antiherpes medicines No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.4.3. Other antivirals Others observations:
Oseltamivir should be used only in compliance with the WHO treatment guidelines, i.e. (1) for treatment of patients with severe or progressive clinical illness with confirmed or suspected influenza pandemic (H1N1) 2009, (2) for the treatment of patients with confirmed or suspected but uncomplicated illness due to pandemic influenza virus infection who were in higher risk groups, most notably for pregnant women and children under 2 years of age.

This medicine is present in:

List Section Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti-Infectives Antivirals No observations

This medicine is present in:

List Section Observation
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations

This medicine is present in:

List Section Observation
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
X 60ML

This medicine is present in:

List Section Observation
Bahamas. Drug Formulary 03. RESPIRATORY DRUGS No observations

This medicine is present in:

List Section Observation
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 05 ANTIVIRALES DE USO SISTÉMICO No observations

This medicine is present in:

List Section Observation
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 05 ANTIVIRALES DE USO SISTÉMICO No observations

This medicine is present in:

List Section Observation
PAHO Strategic Fund Medicine List 2.6.2. Other Antivirals Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti-Infectives Antivirals No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 05. ANTIVIRALES DE USO SISTÉMICO No observations

Information Resources: Oseltamivir

Loading ...
Loading ...
Loading ...
No information available